PG F(2α) Receptor: A Promising Therapeutic Target for Cardiovascular Disease

Overview

Journal Front Pharmacol

Date 2011 May 25

PMID 21607067

Citations 14

Authors

Jian Zhang

Yanjun Gong

Ying Yu

Affiliations

Soon will be listed here.

Abstract

Prostaglandins (PGs), a group of key lipid mediators, are involved in numerous physiological and pathological processes including inflammation and cardiovascular homeostasis. Each PG acts on its specific and distinct cell surface G protein-coupled receptors (GPCRs) or peroxisome proliferator-activated receptors (PPARs). Prostaglandin F(2α) receptor (FP) is required for female reproductive function such as luteolysis and parturition. It has recently been implicated in blood pressure regulation, atherosclerosis and other inflammation-related disorders. The emerging role of FP in cardiovascular diseases is highlighted and potential therapeutic translation is discussed in the current review.

Citing Articles

Systemic investigation of di-isobutyl phthalate (DIBP) exposure in the risk of cardiovascular via influencing the gut microbiota arachidonic acid metabolism in obese mice model.

Liu M, Du X, Chen H, Bai C, Lan L Regen Ther. 2024; 27:290-300.

PMID: 38638558 PMC: 11024931. DOI: 10.1016/j.reth.2024.03.024.

Prostaglandin and prostaglandin receptors: present and future promising therapeutic targets for pulmonary arterial hypertension.

Zeng C, Liu J, Zheng X, Hu X, He Y Respir Res. 2023; 24(1):263.

PMID: 37915044 PMC: 10619262. DOI: 10.1186/s12931-023-02559-3.

Droplet Digital PCR Is a Novel Screening Method Identifying Potential Cardiac G-Protein-Coupled Receptors as Candidate Pharmacological Targets in a Rat Model of Pressure-Overload-Induced Cardiac Dysfunction.

Sayour N, Toth V, Nagy R, Voros I, Gergely T, Onodi Z Int J Mol Sci. 2023; 24(18).

PMID: 37762130 PMC: 10531061. DOI: 10.3390/ijms241813826.

Ligand-induced activation and G protein coupling of prostaglandin F receptor.

Wu C, Xu Y, He Q, Li D, Duan J, Li C Nat Commun. 2023; 14(1):2668.

PMID: 37160891 PMC: 10169810. DOI: 10.1038/s41467-023-38411-x.

PGF facilitates pathological retinal angiogenesis by modulating endothelial FOS-driven ELR CXC chemokine expression.

Zhao Y, Lei Y, Ning H, Zhang Y, Chen G, Wang C EMBO Mol Med. 2022; 15(1):e16373.

PMID: 36511116 PMC: 9832840. DOI: 10.15252/emmm.202216373.

References

Cirillo R, Gillio Tos E, Page P, Missotten M, Quattropani A, Scheer A . Arrest of preterm labor in rat and mouse by an oral and selective nonprostanoid antagonist of the prostaglandin F2alpha receptor (FP). Am J Obstet Gynecol. 2007; 197(1):54.e1-9. DOI: 10.1016/j.ajog.2007.02.010. View

Basu S, Sjoquist B, Resul B, Stjernschantz J . Presence of a 15-ketoprostaglandin delta 13-reductase in porcine cornea. Acta Chem Scand (Cph). 1992; 46(1):108-10. DOI: 10.3891/acta.chem.scand.46-0108. View

Almirza W, Dernison M, Peters P, van Zoelen E, Theuvenet A . Role of the prostanoid FP receptor in action potential generation and phenotypic transformation of NRK fibroblasts. Cell Signal. 2008; 20(11):2022-9. DOI: 10.1016/j.cellsig.2008.07.013. View

Chollet A, Gillio Tos E, Cirillo R . Tocolytic effect of a selective FP receptor antagonist in rodent models reveals an innovative approach to the treatment of preterm labor. BMC Pregnancy Childbirth. 2007; 7 Suppl 1:S16. PMC: 1892057. DOI: 10.1186/1471-2393-7-S1-S16. View

Rader D, Daugherty A . Translating molecular discoveries into new therapies for atherosclerosis. Nature. 2008; 451(7181):904-13. DOI: 10.1038/nature06796. View

Pierce K, Fujino H, Srinivasan D, Regan J . Activation of FP prostanoid receptor isoforms leads to Rho-mediated changes in cell morphology and in the cell cytoskeleton. J Biol Chem. 1999; 274(50):35944-9. DOI: 10.1074/jbc.274.50.35944. View

Seppala E . Production of prostanoids by rheumatic synovial cells in vitro: effects of anti-inflammatory drugs on arachidonic acid metabolism. Clin Rheumatol. 1987; 6(2):170-6. DOI: 10.1007/BF02201019. View

Hao C, Breyer M . Physiological regulation of prostaglandins in the kidney. Annu Rev Physiol. 2007; 70:357-77. DOI: 10.1146/annurev.physiol.70.113006.100614. View

Dinchuk J, Car B, Focht R, Johnston J, Jaffee B, Covington M . Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature. 1995; 378(6555):406-9. DOI: 10.1038/378406a0. View

10.

Fujino T, Nakagawa N, Yuhki K, Hara A, Yamada T, Takayama K . Decreased susceptibility to renovascular hypertension in mice lacking the prostaglandin I2 receptor IP. J Clin Invest. 2004; 114(6):805-12. PMC: 516260. DOI: 10.1172/JCI21382. View

11.

Basu S . Novel cyclooxygenase-catalyzed bioactive prostaglandin F2alpha from physiology to new principles in inflammation. Med Res Rev. 2006; 27(4):435-68. DOI: 10.1002/med.20098. View

12.

Scher J, Pillinger M . The anti-inflammatory effects of prostaglandins. J Investig Med. 2009; 57(6):703-8. DOI: 10.2310/JIM.0b013e31819aaa76. View

13.

Sharif N, Crider J, Davis T . AL-3138 antagonizes FP prostanoid receptor-mediated inositol phosphates generation: comparison with some purported FP antagonists. J Pharm Pharmacol. 2001; 52(12):1529-39. DOI: 10.1211/0022357001777586. View

14.

Basu S, Larsson A, Vessby J, Vessby B, Berne C . Type 1 diabetes is associated with increased cyclooxygenase- and cytokine-mediated inflammation. Diabetes Care. 2005; 28(6):1371-5. DOI: 10.2337/diacare.28.6.1371. View

15.

Bonventre J, Huang Z, Taheri M, OLeary E, Li E, Moskowitz M . Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2. Nature. 1997; 390(6660):622-5. DOI: 10.1038/37635. View

16.

Di Francesco L, Totani L, Dovizio M, Piccoli A, Di Francesco A, Salvatore T . Induction of prostacyclin by steady laminar shear stress suppresses tumor necrosis factor-alpha biosynthesis via heme oxygenase-1 in human endothelial cells. Circ Res. 2009; 104(4):506-13. DOI: 10.1161/CIRCRESAHA.108.191114. View

17.

Friel A, OReilly M, Sexton D, Morrison J . Specific PGF(2alpha) receptor (FP) antagonism and human uterine contractility in vitro. BJOG. 2005; 112(8):1034-42. DOI: 10.1111/j.1471-0528.2005.00658.x. View

18.

Mukhopadhyay P, Bian L, Yin H, Bhattacherjee P, Paterson C . Localization of EP(1) and FP receptors in human ocular tissues by in situ hybridization. Invest Ophthalmol Vis Sci. 2001; 42(2):424-8. View

19.

Weinreb R, Toris C, Gabelt B, Lindsey J, Kaufman P . Effects of prostaglandins on the aqueous humor outflow pathways. Surv Ophthalmol. 2002; 47 Suppl 1:S53-64. DOI: 10.1016/s0039-6257(02)00306-5. View

20.

Funk C . Prostaglandins and leukotrienes: advances in eicosanoid biology. Science. 2001; 294(5548):1871-5. DOI: 10.1126/science.294.5548.1871. View